Zevra Therapeutics Inc <ZVRA.OQ> expected to post earnings of $1.50 a share - Earnings Preview

• Zevra Therapeutics Inc ZVRA.OQ ZVRA.O is expected to show a rise in quarterly revenue when it reports results on August 12 for the period ending June 30 2025

• The Celebration Florida-based company is expected to report a 406.5% increase in revenue to $22.535 million from $4.45 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Zevra Therapeutics Inc is for earnings of $1.50 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Zevra Therapeutics Inc is $25.00, about 51.5% above its last closing price of $12.13

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated August 8 at 21:29 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)